What is Cassava Sciences Inc (SAVA)?
Cassava Sciences Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapies for neurodegenerative diseases. The company primarily targets conditions such as Alzheimer's disease through its research and development efforts. Cassava Sciences engages in the discovery and advancement of drug candidates aimed at addressing the underlying causes of cognitive decline. Its pipeline includes small molecules and other therapeutic agents designed to modify disease progression. The company operates within the biotechnology sector and collaborates with academic institutions and research organizations to support its scientific initiatives. Cassava Sciences is headquartered in the United States and participates in clinical trials to evaluate the safety and efficacy of its drug candidates.
Cassava Sciences Inc Stock Price Today: Live Overview
The price today is shaped by current trading trends, with Filana Therapeutics Inc at $2.01. The price has varied between $1.89 and $2, with a daily change percentage of +3.1088%.
FAQ: Cassava Sciences Inc (SAVA)
What is the current price of SAVA stock?
The latest price stands at $2.01.
Does SAVA pay dividends?
Cassava Sciences Inc. does not currently pay dividends.
Does SAVA have a formal corporate presence or regional headquarters in the UAE?
The company operates without an official regional office, subsidiary, or registered presence in the UAE and conducts business through partners and distributors.
What is SAVA best known for?
Cassava Sciences Inc. is most famous for its focus on developing treatments for neurodegenerative diseases.
What assets are typically shown together with SAVA?
Commonly shown alongside SAVA: ImmuCell, Galapagos NV, Alector, Inc.
Latest shares articles



